Susan J Robertson

Employment

• Murdoch Childrens Research Institute
  2016 - Present
• Royal Melbourne Hospital
  2015 - Present
• Royal Children's Hospital Melbourne
  2014 - Present
• Monash Medical Centre Clayton
  2012 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (44)

• Development of Multidisciplinary Consensus‐Informed Guidance for the Management of Paediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral Hospitals
  Journal of Paediatrics and Child Health 2026 DOI: 10.1111/jpc.70435
  +Save
• Diagnostic delays and patient experiences in erythropoietic protoporphyria: a multi-site study in Australia
  British Journal of Dermatology 2026 DOI: 10.1093/bjd/ljag114
  +Save
• Acute Infusion Pain Reaction Due to Anti‐PD‐1 Antibodies for the Treatment of Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Case Report and Review of the Literature
  Case Reports in Dermatological Medicine 2025 DOI: 10.1155/crdm/4558623
  +Save
• Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES).
  Orphanet journal of rare diseases 2024 DOI: 10.1186/s13023-024-03349-w
  +Save
• A case of dermatopathia pigmentosa reticularis masquerading as dyskeratosis congenita: the importance of nailing the correct diagnosis.
  Clinical and experimental dermatology 2024 DOI: 10.1093/ced/llae310
  +Save
• Paediatric indications and dosing guidance for advanced targeted treatments in Australia
  Australasian Journal of Dermatology 2024 DOI: 10.1111/ajd.14230
  +Save
• Follicular Becker nevus: A case series and brief literature review
  Pigment International 2024 DOI: 10.4103/pigmentinternational_43_23
  +Save
• Naevoid miliaria profunda, successfully treated with botulinum toxin.
  The Australasian journal of dermatology 2024 DOI: 10.1111/ajd.14256
  +Save
• Toxic epidermal necrolysis: A rare and life-threatening condition.
  Australian journal of general practice 2024 DOI: 10.31128/ajgp-05-23-6831
  +Save
• Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: Findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study
  Skin Health and Disease 2024 DOI: 10.1002/ski2.314
  +Save
• Improving genetic diagnostic yield in a large cohort of children with rare vascular anomalies or PIK3CA-related overgrowth spectrum
  Genetics in Medicine Open 2024 DOI: 10.1016/j.gimo.2023.100837
  +Save
• Skin fragility disorder misdiagnosed as child abuse: a cautionary tale.
  The Medical journal of Australia 2023 DOI: 10.5694/mja2.52188
  +Save
• Delayed linear lipoatrophy following corticosteroid injection of a hypertrophic scar: Successfully reversed by isotonic saline injection
  Australasian Journal of Dermatology 2023 DOI: 10.1111/ajd.14135
  +Save
• Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study.
  Orphanet journal of rare diseases 2023 DOI: 10.1186/s13023-023-02817-z
  +Save
• A red scaly rash to the groin
  Australian Journal of General Practice 2023 DOI: 10.31128/ajgp-03-22-6372
  +Save
• Gold weight implants for cicatricial lagophthalmos in epidermolysis bullosa.
  Clinical and experimental dermatology 2023 DOI: 10.1093/ced/llad016
  +Save
• A blistering cutaneous lesion in an infant
  Australian Journal of General Practice 2022 DOI: 10.31128/ajgp-03-22-6378
  +Save
• Discoid (nummular) eczema in the paediatric setting – An Australian/New Zealand narrative
  Australasian Journal of Dermatology 2022 DOI: 10.1111/ajd.13915
  +Save
• Clinical overlap of PHACE and LUMBAR syndromes
  Pediatric Dermatology 2022 DOI: 10.1111/pde.15031
  +Save
• A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e‐Delphi process and consensus meeting
  British Journal of Dermatology 2022 DOI: 10.1111/bjd.21723
  +Save